Paul Singer’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,800,000	Closed	-$384M	–	63
2024 Q2	$384M	Buy	2,800,000 +550,000	+24%	+$73.4M	2.22%	9
2024 Q1	$309M	Sell	2,250,000 -3,997,600	-64%	-$546M	1.92%	12
2023 Q4	$849M	Buy	6,247,600 +1,630,000	+35%	+$199M	4.53%	7
2023 Q3	$565M	Buy	4,617,600 +4,159,600	+908%	+$529M	4.37%	6
2023 Q2	$58.1M	Sell	458,000 -98,600	-18%	-$12.8M	0.51%	34
2023 Q1	$71.9M	Sell	556,600 -893,400	-62%	-$117M	0.53%	26
2022 Q4	$190M	Hold	1,450,000	–	–	1.55%	16
2022 Q3	$170M	Buy	1,450,000 +780,000	+116%	+$96.9M	1.76%	14
2022 Q2	$78.8M	Buy	+670,000	New	+$79.5M	0.91%	23
2021 Q2	–	Sell	-704,000	Closed	-$106M	–	59
2021 Q1	$106M	Hold	704,000	–	–	0.79%	28
2020 Q4	$107M	Sell	704,000 -721,000	-51%	-$103M	1.04%	22
2020 Q3	$193M	Buy	1,425,000 +300,000	+27%	+$40.7M	2.02%	14
2020 Q2	$154M	Buy	+1,125,000	New	+$143M	1.67%	13